DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C1845667 | RETINITIS PIGMENTOSA 3 | COG4 | 25839 | component of oligomeric golgi complex 4 | Q9H9E3 |
C0003635 | Apraxias | COG4 | 25839 | component of oligomeric golgi complex 4 | Q9H9E3 |
C0235946 | Cerebral atrophy | COG4 | 25839 | component of oligomeric golgi complex 4 | Q9H9E3 |
C0005779 | Blood Coagulation Disorders | COG4 | 25839 | component of oligomeric golgi complex 4 | Q9H9E3 |
C0027947 | Neutropenia | COG4 | 25839 | component of oligomeric golgi complex 4 | Q9H9E3 |
C0025958 | Microcephaly | COG4 | 25839 | component of oligomeric golgi complex 4 | Q9H9E3 |
C3888417 | CATARACT 5, MULTIPLE TYPES | COG4 | 25839 | component of oligomeric golgi complex 4 | Q9H9E3 |
C0086543 | Cataract | COG4 | 25839 | component of oligomeric golgi complex 4 | Q9H9E3 |
C0520947 | Clumsiness - motor delay | COG4 | 25839 | component of oligomeric golgi complex 4 | Q9H9E3 |
C1837461 | SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3 | CHODL | 140578 | chondrolectin | Q9H9P2 |
C0007131 | Non-Small Cell Lung Carcinoma | CHODL | 140578 | chondrolectin | Q9H9P2 |
C0684249 | Carcinoma of lung | CHODL | 140578 | chondrolectin | Q9H9P2 |
C2267227 | Bulimia Nervosa | CHODL | 140578 | chondrolectin | Q9H9P2 |
C0026847 | Spinal Muscular Atrophy | CHODL | 140578 | chondrolectin | Q9H9P2 |
C0027651 | Neoplasms | CHODL | 140578 | chondrolectin | Q9H9P2 |
C0086237 | Epilepsy, Cryptogenic | L2HGDH | 79944 | L-2-hydroxyglutarate dehydrogenase | Q9H9P8 |
C1855995 | L-2-HYDROXYGLUTARIC ACIDURIA | L2HGDH | 79944 | L-2-hydroxyglutarate dehydrogenase | Q9H9P8 |
C2746066 | Combined D-2- and L-2-hydroxyglutaric aciduria | L2HGDH | 79944 | L-2-hydroxyglutarate dehydrogenase | Q9H9P8 |
C0017636 | Glioblastoma | L2HGDH | 79944 | L-2-hydroxyglutarate dehydrogenase | Q9H9P8 |
C3714756 | Intellectual Disability | L2HGDH | 79944 | L-2-hydroxyglutarate dehydrogenase | Q9H9P8 |
C0028738 | Nystagmus | L2HGDH | 79944 | L-2-hydroxyglutarate dehydrogenase | Q9H9P8 |
C0013421 | Dystonia | L2HGDH | 79944 | L-2-hydroxyglutarate dehydrogenase | Q9H9P8 |
C0036572 | Seizures | L2HGDH | 79944 | L-2-hydroxyglutarate dehydrogenase | Q9H9P8 |
C0278878 | Adult Glioblastoma | L2HGDH | 79944 | L-2-hydroxyglutarate dehydrogenase | Q9H9P8 |
C0025517 | Metabolic Diseases | L2HGDH | 79944 | L-2-hydroxyglutarate dehydrogenase | Q9H9P8 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024